BioAtla (BCAB) Share-based Compensation (2020 - 2026)
BioAtla (BCAB) reported Share-based Compensation of $619,000 for Q2 2026, down 55.0% from $1.38 million a year earlier and down 35.3% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Share-based Compensation (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioAtla's Share-based Compensation came in at $3.99 million, down 44.2% year-over-year; for FY2025, it came in at $5.43 million, down 39.1% from FY2024.
- Share-based Compensation has declined for four consecutive years, though with a five-year compound annual growth rate of 12.5% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $8.92 million in FY2024 (-34.1%), $13.54 million in FY2023 (-7.0%), $14.56 million in FY2022 (-42.0%) and $25.12 million in FY2021 (+731.1%).
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation in data going back to Q4 2020.
- Year over year, Share-based Compensation has now declined in each of the last 18 quarters, with an average decline of 40.1% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 26.1%); the low point was Q2 2022 (a decline of 68.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $956,000 (Q1 2026), $1.12 million (Q4 2025) and $1.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - | 619,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 619,000.00 |
| Mar 31, 2026 | 956,000.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.30 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 3.61 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 4.37 Mn |
API Access
BioAtla Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();